Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Oldhamrobert K. Cancer biotherapy: more than immunotherapy. Cancer Biother Radiopharm. 2017;32(4):111–114. doi:10.1089/cbr.2017.28999.old28514209
   PubMedGoogle Scholar
• Robison JG, Smith CL. Therapeutic massage during chemotherapy and/or biotherapy infusions: patient perceptions of pain, fatigue, nausea, anxiety, and satisfaction. Clin J Oncol Nurs. 2016;20(2):E34–E40. doi:10.1188/16.CJON.E34-E4026991721
   PubMedGoogle Scholar
• Gupta HB, Clark CA, Yuan B, et al. Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer. Signal Transduct Target Ther. 2016;1(1):16030. doi:10.1038/sigtrans.2016.3028798885
   PubMedGoogle Scholar
• Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):7. doi:10.1038/s41392-017-0004-329560283
   PubMed Web of Science ®Google Scholar
• Kotterman MA, Schaffer DV. Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet. 2014;15(7):445–451. doi:10.1038/nrg374224840552
   PubMed Web of Science ®Google Scholar
• Naldini L. Gene therapy returns to centre stage. Nature. 2015;526(7573):351–360. doi:10.1038/nature1581826469046
   PubMed Web of Science ®Google Scholar
• Kotterman MA, Chalberg TW, Schaffer DV. Viral vectors for gene therapy: translational and clinical outlook. Annu Rev Biomed Eng. 2015;17:63–89. doi:10.1146/annurev-bioeng-071813-10493826643018
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Mason PW, Geall A, Mandl CW. RNA-based vaccines. Vaccine. 2012;30(30):4414–4418. doi:10.1016/j.vaccine.2012.04.06022546329
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gascon A, del Pozo-Rodriguez A, Solinis MA. Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles. Int J Nanomedicine. 2014;9:1833–1843. doi:10.2147/IJN.S3981024748793
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Geall AJ. Recent innovations in mRNA vaccines. Curr Opin Immunol. 2016;41:18–22. doi:10.1016/j.coi.2016.05.00827240054
   PubMed Web of Science ®Google Scholar
• Whitworth KM, Cecil R, Benne JA, et al. Zygote injection of RNA encoding Cre recombinase results in efficient removal of LoxP flanked neomycin cassettes in pigs. Transgenic Res. 2018;27(2):167–178. doi:10.1007/s11248-018-0064-329516259
   PubMedGoogle Scholar
• Midoux P, Pichon C. Lipid-based mRNA vaccine delivery systems. Expert Rev Vaccines. 2015;14(2):221–234. doi:10.1586/14760584.2015.98610425540984
   PubMed Web of Science ®Google Scholar
• Grabbe S, Haas H, Diken M, Kranz LM, Langguth P, Sahin U. Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma. Nanomedicine (Lond). 2016;11(20):2723–2734. doi:10.2217/nnm-2016-027527700619
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Kormann M, Rosenecker J, Rudolph C. Current prospects for mRNA gene delivery. Eur J Pharm Biopharm. 2009;71(3):484–489. doi:10.1016/j.ejpb.2008.09.01618948192
   PubMed Web of Science ®Google Scholar
• Youn H, Chung J-K. Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy. Expert Opin Biol Ther. 2015;15(9):1337–1348. doi:10.1517/14712598.2015.105756326125492
   PubMed Web of Science ®Google Scholar
• Geall AJ, Mandl CW, Ulmer JB. RNA: the new revolution in nucleic acid vaccines. Semin Immunol. 2013;25(2):152–159. doi:10.1016/j.smim.2013.05.00123735226
   PubMed Web of Science ®Google Scholar
• Guo C, Manjili MH, Subjeck JR, Sarkar D, Fisher PB, Wang X-Y. Therapeutic cancer vaccines: past, present, and future. Adv Cancer Res. 2013;119:421–475. doi:10.1016/B978-0-12-407190-2.00007-123870514
   PubMed Web of Science ®Google Scholar
• Schalper KA, Velcheti V, Carvajal D, et al. In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas. Clin Cancer Res. 2014;20(10):2773–2782. doi:10.1158/1078-0432.CCR-13-270224647569
   PubMed Web of Science ®Google Scholar
• Sahin U, Kariko K, Tureci O. mRNA-based therapeutics—developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759–780. doi:10.1038/nrd427825233993
   PubMed Web of Science ®Google Scholar
• Persano S. A self-assembled non-viral vector as potential platform for mRNA-based vaccines. Transl Biomed. 2017;8(3). doi:10.21767/2172-0479.100119
   Google Scholar
• Pollard C, De Koker S, Saelens X, Vanham G, Grooten J. Challenges and advances towards the rational design of mRNA vaccines. Trends Mol Med. 2013;19(12):705–713. doi:10.1016/j.molmed.2013.09.00224138818
   PubMed Web of Science ®Google Scholar
• Li B, Zhang X, Dong Y. Nanoscale platforms for messenger RNA delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018;11(2):e1530. doi:10.1002/wnan.1530.29726120
   PubMedGoogle Scholar
• Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, Rejman J. mRNA as gene therapeutic: how to control protein expression. J Control Release. 2011;150(3):238–247. doi:10.1016/j.jconrel.2010.10.02020970469
   PubMed Web of Science ®Google Scholar
• Bi Y, Zhang Y, Cui C, Ren L, Jiang X. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7. Int J Nanomedicine. 2016;11:5771–5787. doi:10.2147/IJN.S11761127853365
   PubMed Web of Science ®Google Scholar
• Duan X, Wang P, Men K, et al. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles. Nanoscale. 2012;4(7):2400–2407. doi:10.1039/c2nr30079f22388488
   PubMedGoogle Scholar
• Zhang L, Gao X, Men K, et al. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A. Int J Nanomedicine. 2011;6:2419–2427. doi:10.2147/IJN.S2358222072877
   PubMed Web of Science ®Google Scholar
• Persano S, Guevara ML, Li Z, et al. Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination. Biomaterials. 2017;125:81–89. doi:10.1016/j.biomaterials.2017.02.01928231510
   PubMed Web of Science ®Google Scholar
• Kauffman KJ, Webber MJ, Anderson DG. Materials for non-viral intracellular delivery of messenger RNA therapeutics. J Control Release. 2016;240:227–234. doi:10.1016/j.jconrel.2015.12.03226718856
   PubMed Web of Science ®Google Scholar
• McKinlay CJ, Vargas JR, Blake TR, et al. Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals. Proc Natl Acad Sci U S A. 2017;114(4):E448–E456. doi:10.1073/pnas.161419311428069945
   PubMed Web of Science ®Google Scholar
• Chen X, Wang X, Wang Y, et al. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J Control Release. 2010;145(1):17–25. doi:10.1016/j.jconrel.2010.03.00720307599
   PubMed Web of Science ®Google Scholar
• Koivusalo M, Welch C, Hayashi H, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188(4):547–563. doi:10.1083/jcb.20090808620156964
   PubMed Web of Science ®Google Scholar
• Jia H-R, Zhu Y-X, Xu K-F, Liu X, Wu F-G. Plasma membrane-anchorable photosensitizing nanomicelles for lipid raft-responsive and light-controllable intracellular drug delivery. J Control Release. 2018;286:103–113. doi:10.1016/j.jconrel.2018.07.02730026079
   PubMed Web of Science ®Google Scholar
• Lacerda L, Russier J, Pastorin G, et al. Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials. 2012;33(11):3334–3343. doi:10.1016/j.biomaterials.2012.01.02422289266
   PubMed Web of Science ®Google Scholar
• Hu Q, Gu G, Liu Z, et al. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Biomaterials. 2013;34(4):1135–1145. doi:10.1016/j.biomaterials.2012.10.04823146434
   PubMed Web of Science ®Google Scholar
• Bewersdorff T, Vonnemann J, Kanik A, Haag R, Haase A. The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles. Int J Nanomedicine. 2017;12:2001–2019. doi:10.2147/IJN.S12429528352171
   PubMed Web of Science ®Google Scholar
• Shiao SL, Ganesan AP, Rugo HS, Coussens LM. Immune microenvironments in solid tumors: new targets for therapy. Genes Dev. 2011;25(24):2559–2572. doi:10.1101/gad.169029.11122190457
   PubMed Web of Science ®Google Scholar
• Lee K, Yu P, Lingampalli N, Kim HJ, Tang R, Murthy N. Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells. Int J Nanomedicine. 2015;10:1841–1854. doi:10.2147/IJN.S7512425834424
   PubMed Web of Science ®Google Scholar
• Li J, Wang W, He Y, et al. Structurally programmed assembly of translation initiation nanoplex for superior mRNA delivery. ACS Nano. 2017;11(3):2531–2544. doi:10.1021/acsnano.6b0844728157292
   PubMed Web of Science ®Google Scholar
• Li J, He Y, Wang W, Wu C, Hong C, Hammond PT. Polyamine-mediated stoichiometric assembly of ribonucleoproteins for enhanced mRNA delivery. Angew Chem (Int Ed Engl). 2017;56(44):13709–13712. doi:10.1002/anie.20170746628925033
   PubMedGoogle Scholar
• Choi HY, Lee T-J, Yang G-M, et al. Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells. J Control Release. 2016;235:222–235. doi:10.1016/j.jconrel.2016.06.00727266364
   PubMed Web of Science ®Google Scholar
• Li J, Sun Y, Jia T, Zhang R, Zhang K, Wang L. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer. Int J Cancer. 2014;134(7):1683–1694. doi:10.1002/ijc.2848224105486
   PubMed Web of Science ®Google Scholar
• Zou S, Scarfo K, Nantz MH, Hecker JG. Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. Int J Pharm. 2010;389(1–2):232–243. doi:10.1016/j.ijpharm.2010.01.01920080162
   PubMedGoogle Scholar